The association of appendicular lean mass and grip strength with low-density lipoprotein, very low-density lipoprotein, and high-density lipoprotein particle diameter: a Mendelian randomization study of the UK Biobank cohort

被引:0
作者
Kirwan, Richard [1 ,2 ]
Mazidi, Mohsen [2 ,3 ,4 ]
Butler, Tom [5 ]
de Heredia, Fatima Perez [6 ]
Lip, Gregory Y. H. [2 ,7 ]
Davies, Ian G. [1 ,2 ]
机构
[1] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool, England
[2] Univ Liverpool, Liverpool John Moores Univ, Liverpool Heart & Chest Hosp, Liverpool Ctr Cardiovasc Sci, Liverpool, England
[3] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Epidemiol Studies Unit, Old Rd Campus, Roosevelt Dr, Doll Bldg, Oxford OX3 7LF, England
[4] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England
[5] Edge Hill Univ, Fac Hlth Social Care & Med, Sch Appl Hlth & Social Care & Social Work, Ormskirk L39 4QP, England
[6] Liverpool John Moores Univ, Sch Biol & Environm Sci, Liverpool, England
[7] Aalborg Univ, Danish Ctr Clin Hlth Serv Res, Dept Clin Med, Aalborg, Denmark
来源
EUROPEAN HEART JOURNAL OPEN | 2024年 / 4卷 / 02期
关键词
Muscle mass; Mendelian randomization; Low-density lipoprotein; Sarcopenia; Lean mass; Lipoprotein diameter; High-density lipoprotein; CORONARY-HEART-DISEASE; HDL-CHOLESTEROL LEVELS; CARDIOVASCULAR-DISEASE; SKELETAL-MUSCLE; RICH LIPOPROTEINS; CAUSAL INFERENCE; RISK-FACTORS; FAT MASS; INSTRUMENTS; EXERCISE;
D O I
10.1093/ehjopen/oeae019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Reduced muscle mass and reduced strength are frequently associated with both alterations in blood lipids and poorer cardiometabolic outcomes in epidemiological studies; however, a causal association cannot be determined from such observations. Two-sample Mendelian randomization (MR) was applied to assess the association of genetically determined appendicular lean mass (ALM) and handgrip strength (HGS) with serum lipid particle diameter. Methods and results Mendelian randomization was implemented using summary-level data from the largest genome-wide association studies on ALM (n = 450 243), HGS (n = 223 315), and lipoprotein [low-density lipoprotein (LDL), very LDL (VLDL), and high-density lipoprotein (HDL)] particle diameters (n = 115 078). Inverse variance-weighted (IVW) method was used to calculate the causal estimates. Weighted median-based method, MR-Egger, and leave-one-out method were applied as sensitivity analysis. Greater ALM had a statistically significant positive effect on HDL particle diameter (MR-Egger: beta = 0.055, SE = 0.031, P = 0.081; IVW: beta = 0.068, SE = 0.014, P < 0.001) and a statistically significant negative effect on VLDL particle diameter (MR-Egger: beta = -0.114, SE = 0.039, P = 0.003; IVW: beta = -0.081, SE = 0.017, P < 0.001). Similarly, greater HGS had a statistically significant positive effect on HDL particle diameter (MR-Egger: beta = 0.433, SE = 0.184, P = 0.019; IVW: beta = 0.121, SE = 0.052, P = 0.021) and a statistically significant negative effect on VLDL particle diameter (MR-Egger: beta = -0.416, SE = 0.163, P = 0.011; IVW: beta = -0.122, SE = 0.046, P = 0.009). There was no statistically significant effect of either ALM or HGS on LDL particle diameter. Conclusion There were potentially causal associations between both increasing ALM and HGS and increasing HDL particle size and decreasing VLDL particle size. These causal associations may offer possibilities for interventions aimed at improving cardiovascular disease risk profile. Higher levels of muscle mass in the arms and legs and grip strength are associated with larger high-density lipoprotein particles and smaller very low-density lipoprotein particles in the blood, which may indicate a lower risk of some forms of heart disease.
引用
收藏
页数:10
相关论文
共 74 条
[1]   Mechanical muscle function, morphology, and fiber type in lifelong trained elderly [J].
Aagaard, Per ;
Magnusson, Peter S. ;
Larsson, Benny ;
Kjaer, Michael ;
Krustrup, Peter .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2007, 39 (11) :1989-1996
[2]  
Abe T, 1994, J Atheroscler Thromb, V1, P15
[3]   Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome [J].
Adiels, Martin ;
Olofsson, Sven-Olof ;
Taskinen, Marja-Riitta ;
Boren, Jan .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (07) :1225-1236
[4]   Comparison of 2 Weekly Frequencies of Resistance Training on Muscular Strength, Body Composition, and Metabolic Biomarkers in Resistance-Trained Older Women: Effects of Detraining and Retraining [J].
Amarante do Nascimento, Matheus ;
Nunes, Joao Pedro ;
Pina, Fabio L. C. ;
Ribeiro, Alex S. ;
Carneiro, Nelson H. ;
Venturini, Danielle ;
Barbosa, Decio S. ;
Mayhew, Jerry L. ;
Cyrino, Edilson S. .
JOURNAL OF STRENGTH AND CONDITIONING RESEARCH, 2022, 36 (05) :1437-1444
[5]  
[Anonymous], 2021, UK Biobank-Body composition measurement
[6]   HDL particle size and the risk of coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study [J].
Arsenault, Benoit J. ;
Lemieux, Isabelle ;
Despres, Jean-Pierre ;
Gagnon, Pascale ;
Wareham, Nicholas J. ;
Stroes, Erik S. G. ;
Kastelein, John J. P. ;
Khaw, Kay-Tee ;
Boekholdt, S. Matthijs .
ATHEROSCLEROSIS, 2009, 206 (01) :276-281
[7]   Sarcopenia and the cardiometabolic syndrome: A narrative review [J].
Bahat, G. ;
Ilhan, B. .
EUROPEAN GERIATRIC MEDICINE, 2016, 7 (03) :220-223
[8]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[9]   VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins [J].
Balling, Mie ;
Afzal, Shoaib ;
Varbo, Anette ;
Langsted, Anne ;
Smith, George Davey ;
Nordestgaard, Borge G. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (23) :2725-2735
[10]   Effects of torcetrapib in patients at high risk for coronary events [J].
Barter, Philip J. ;
Caulfield, Mark ;
Eriksson, Mats ;
Grundy, Scott M. ;
Kastelein, John J. P. ;
Komajda, Michel ;
Lopez-Sendon, Jose ;
Mosca, Lori ;
Tardif, Jean-Claude ;
Waters, David D. ;
Shear, Charles L. ;
Revkin, James H. ;
Buhr, Kevin A. ;
Fisher, Marian R. ;
Tall, Alan R. ;
Brewer, Bryan .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) :2109-2122